Coronary Artery Ectasia: A 10-Year Experience at a Single Center in Saudi Arabia

Talal F Aljabbary1, Meshal S Alhamed1, Mohamed H Ismaeel1,2

  • 1Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Insights

Coronary artery ectasia (CAE) affects 2.3% of patients in Saudi Arabia, predominantly males. Isolated CAE shows better outcomes than when combined with atherosclerotic cardiovascular disease (ASCVD).

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Coronary artery ectasia (CAE) is an uncommon angiographic finding.
  • Its prevalence, clinical characteristics, and long-term outcomes, particularly in Saudi Arabia, require further elucidation.

Purpose of the Study:

  • To determine the incidence of coronary artery ectasia (CAE).
  • To investigate the clinical characteristics and outcomes of CAE patients in Saudi Arabia over a decade.

Main Methods:

  • Retrospective analysis of coronary angiography procedures from January 2013 to June 2023.
  • Inclusion of patients diagnosed with CAE.

Main Results:

  • An incidence of 2.3% for CAE was observed in 10,397 patients.
  • The majority of CAE patients were male (92.6%), with a mean age of 57.15 years.
  • Diffuse ectasia was most common (92.5%), affecting the RCA in 65.2%. Mixed CAE and atherosclerotic cardiovascular disease (ASCVD) showed higher rates of diabetes and smoking.
  • Patients with mixed CAE and ASCVD had significantly higher composite endpoint rates (29% vs. 14%) during follow-up.

Conclusions:

  • CAE is an infrequent finding, often associated with obstructive coronary artery disease (CAD).
  • Outcomes differ based on the presence of obstructive disease; isolated CAE is associated with fewer adverse events.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...